Mercom: Telemedicine investments led 2020's $14.8B in digital health fundraising

While equity investments in telemedicine rose 139% to $4.3 billion, other areas like data analytics and mobile health apps also earned strong support from investors.
By Dave Muoio
11:19 am

Mercom Capital Group has released its tally of 2020's digital health funding: $14.8 billion in equity raised across 637 deals, as well as $6.8 billion in debt and public market financing across 26 deals.

These represent a respective 66% and 278% increase over the firm's count for 2019, according to the Mercom report released yesterday. In total, 1,694 different investors took part in these deals.

In addition, the firm tracked a total of 184 mergers and acquisitions during the past year, a slight increase over the 169 transactions of 2019.

Looking at the fourth quarter of 2020 alone, Mercom's report highlights 139 equity funding deals totaling $4.5 billion, a 165% increase over Q4 2019.


Beyond illustrating the staggering weight of investments digital health claimed during a year of pandemic, Mercom's breakdown identifies specific areas within the industry that received extra love from investors.

Standing at the top was telemedicine, which according to the report brought in $4.3 billion across the entire year (up 139% from last year's $1.8 billion). Following in its wake were investments into data analytics startups ($1.8 billion), mobile health apps ($1.4 billion), clinical decision support tools ($1.2 billion), practice management solutions ($837 million) and wearable sensors ($8.15).

(Image courtesy of Mercom Capital Group, a research and communication firm focused on digital health and cleantech.)

“COVID-19 supercharged funding activity in digital health in 2020," Raj Prabhu, CEO of Mercom Capital Group, said in a statement. "Ten digital health categories had their best year with record funding amounts." 

Two other major trends were also highlighted in the report: the strong performance of 2020's digital health IPOs and the growing interest in consumer-facing digital health. For the former, Mercom noted a total of $6.2 billion generated by the year's IPOs was a major increase over last years $1.4 billion.

"It was also the biggest year for IPOs," Prabhu said. "We could see a lot more companies going public in 2021 if the current IPO and SPAC boom continues.”

Consumer-centric companies, meanwhile, increased their fundraising haul 81% year over year, with a total $9.6 billion.

"The pandemic has mainstreamed the consumer side of digital health technologies in less than a year," Prabhu said. "Digital health products that were a novelty a year or two ago are now a necessity."

Companies focused on healthcare practices also upped their annual raises by 47%, to $5.3 billion.


Mercom's numbers and trends generally fall in line with MobiHealthNews' observations, which pegged the year's raises at about $14 billion.

Our reporting and accounts from others watching the space throughout the year have generally identified 2020 as a breakout year as the market placed new weight on the benefits of virtual health technologies.

There was some speculation that the fervor had cooled a bit halfway through the final quarter, although this was counteracted by a strong finish from big names like Verily, DXY, Olive, Everlywell and Cityblock Health.


The latest news in digital health delivered daily to your inbox.

Thank you for subscribing!
Error! Something went wrong!